Pyratel EQ, 132 mg/ml, oral antiparasitic paste for horses

COMPOSITION
1 ml of oral paste contains:
Active substance:
Pyrantel ………………………………………………………………………………..132 mg
(the equivalent to 380.9 mg/ml of pyrantel pamoate)
Excipients:
Methyl parahydroxybenzoate …………………………………………………….2 mg
Propyl parahydroxybenzoate ………………………………………………….0.2 mg
Propylene glycol, PVP K 30, polysorbate 80, glycerin, lactose,
magnesium stearate, sorbitol, cetostearyl alcohol, xanthan gum,
sodium metabisulfite, purified water.
INDICATIONS
It is used in horses for the control of endoparasites produced
by nematodes (Strongylus vulgaris, Strongylus edentatus and
Strongylus equinus, Oxyuris equi, Parascaris equorum) and cestodes
(Anoplocephala spp.).
CONTRAINDICATIONS
Do not administer to debilitated animals.
Do not administer in case of hypersensitivity to the active substance
or to any of the excipients.
ADVERSE REACTIONS
Administered as directed, no adverse reactions have been reported.
TARGET SPECIES
Horses
ADMINISTRATION
PYRATEL EQ, paste, is administered orally. The dose varies
depending on the weight of the animal undergoing treatment, as
follows:
• for cestodes (tapeworms) double doses are used compared to those
used in the treatment of gastrointestinal nematodes, namely 10 ml
of paste/ 100 kg b.w.
• for nematodes, the dose is 660 mg pyratel base/100 kg b.w.
respectively a gradation (5 ml of paste/100 kg b.w.). The contents of
a syringe ensures the treatment of an animal of 600 kg b.w..
The horses and ponies over 8 months are dewormed every 6 weeks.
The foals between 2-8 months will be dewormed monthly. The
pregnant mares are dewormed 1 month before foaling, the treatment
being repeated at 10-14 days after foaling .
For administration, the ring on the graduated plunger of the syringe
is fixed according to the weight, the syringe is inserted in the oral
cavity of the horse, in the interdental space, as deep as possible,
depositing the product at the base of the tongue. Immediately after
administration, the animal’s head is raised for a few seconds. Before
administering the product, one must ensure that there is no feed in
the oral cavity. In order to ensure a correct dosage, the body weight
must be determined as accurately as possible.
RECOMMENDATIONS FOR PROPER ADMINISTRATION
For the administration, care should be taken to remove any feed
residues from the oral cavity of the animals.
USE IN THE CASE OF PREGNANCY, LACTATION
It can be used during pregnancy and lactation.
INTERACTIONS WITH OTHER MEDICINAL PRODUCTS OR OTHER
FORMS OF INTERACTION
The simultaneous treatment with products containing: morantel,
levamisole, piperazine and organophosphorus compounds is not
recommended.
OVERDOSE
Pyratel pamoate is moderately toxic. When administered to horses
at a dose 20 times higher than recommended, it did not cause
adverse reactions.
INCOMPATIBILITIES
The simultaneous treatment with products containing: morantel,
levamisole, piperazine and organophosphorus compounds. In
absence of compatibility studies, this veterinary medicinal product
should not be administered simultaneously with other veterinary
medicinal products.
WITHDRAWAL PERIOD
Meat and offal: zero days
STORAGE
Store at a temperature below 25°C. Keep in the original packaging.
Keep the packaging tightly closed. Protect from light direct. Protect
from frost.

PRESENTATION
Dosing syringes x 30 ml